Neat Digest  ·  Archive  ·  Open in app ↗

Merck and Kelun's lung cancer combo bests Keytruda in late-stage trial

Score 7.1/10 · Significant · Health · 1 sources · May 22, 2026
Merck and Kelun's lung cancer combo bests Keytruda in late-stage trial

Summary: Merck & Co. and Kelun-Biotech announced positive results from...

Sources on this story

Reported by 1 sources, including:

  • Seeking Alpha